About this Journal Submit a Manuscript Table of Contents
Experimental Diabetes Research
Volume 2012 (2012), Article ID 924168, 7 pages
http://dx.doi.org/10.1155/2012/924168
Review Article

A Review on the Association between Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer

1Department of Internal Medicine, National Taiwan University College of Medicine, Taipei 10002, Taiwan
2Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan

Received 15 February 2012; Accepted 1 April 2012

Academic Editor: Chien-Jen Chen

Copyright © 2012 Wei-Yih Chiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Kiran S. Panickar, “Effects of dietary polyphenols on neuroregulatory factors and pathways that mediate food intake and energy regulation in obesity,” Molecular Nutrition & Food Research, vol. 57, no. 1, pp. 34–47, 2012. View at Publisher · View at Google Scholar
  • Baptist Gallwitz, “Incretin for the continuing treatment of secondary failure to metformin in Type 2 diabetes,” Diabetes Management, vol. 3, no. 4, pp. 323–331, 2013. View at Publisher · View at Google Scholar
  • Franziska Boess, Cristina Bertinetti-Lapatki, Sannah Zoffmann, Catherine George, Thomas Pfister, Adrian Roth, Serene M. L. Lee, Wolfgang E. Thasler, Thomas Singer, and Laura Suter, “Effect of GLP1R agonists taspoglutide and liraglutide on primary thyroid C-cells from rodent and man,” Journal Of Molecular Endocrinology, vol. 50, no. 3, pp. 325–336, 2013. View at Publisher · View at Google Scholar
  • Chin-Hsiao Tseng, “Diabetes and thyroid cancer mortality: a 12-year prospective follow-up of Taiwanese,” European Journal of Clinical Investigation, vol. 43, no. 6, pp. 595–601, 2013. View at Publisher · View at Google Scholar
  • Chin-Hsiao Tseng, “Diabetes, insulin use, smoking, and pancreatic cancer mortality in Taiwan,” Acta Diabetologica, 2013. View at Publisher · View at Google Scholar
  • Claudia E. Reusch, and Isabelle Padrutt, “New Incretin Hormonal Therapies in Humans Relevant to Diabetic Cats,” Veterinary Clinics of North America: Small Animal Practice, vol. 43, no. 2, pp. 417–433, 2013. View at Publisher · View at Google Scholar
  • Thomas J. Rosol, “On-target effects of GLP-1 receptor agonists on thyroid C-cells in rats and mice,” Toxicologic Pathology, vol. 41, no. 2, pp. 303–309, 2013. View at Publisher · View at Google Scholar
  • Hale M. Tasyurek, Hasan Ali Altunbas, Mustafa Kemal Balci, and Salih Sanlioglu, “Incretins: Their physiology and application in the treatment of diabetes mellitus,” Diabetes/Metabolism Research and Reviews, vol. 30, no. 5, pp. 354–371, 2014. View at Publisher · View at Google Scholar
  • D. Roy, K. D. Chadwick, K. Tatarkiewicz, C. LaCerte, A.-M. Bergholm, T. Brodie, R. S. Mangipudy, D. Parkes, M. J. Graziano, and T. P. Reilly, “The glucagon-like peptide-1-based therapeutics exenatide and saxagliptin did not cause detrimental effects on the pancreas in mice, rats, dogs and monkeys,” Diabetes, Obesity and Metabolism, 2014. View at Publisher · View at Google Scholar
  • Chin-Hsiao Tseng, “A Review on Thiazolidinediones and Bladder Cancer in Human Studies,” Journal of Environmental Science and Health Part C-Environmental Carcinogen, vol. 32, no. 1, pp. 1–45, 2014. View at Publisher · View at Google Scholar